JAMDA
April 30, 2024
Showing 4401 - 4410 of 7353 results
Policy Snapshot
June 7, 2024
National Coverage Determination 200.3: Monoclonal Antibodies for the Treatment of Alzheimer’s Disease
Learn about coverage for monoclonal antibodies for the treatment of Alzheimer’s disease, effective April 7, 2022.
Spotlight
February 1, 2024
National Dementia Workforce Study Needs Your Input
AMDA members are often on the frontlines of dementia care, so it’s only appropriate that they be involved in the National Dementia Workforce Study, which involves surveying those individuals who work in homes, hospitals, clinics, assisted living facilities, and nursing homes to gain data to improve care an...
JAMDA
February 20, 2023
National Early Warning Scores Following Emergency Hospital Transfer: Implications for Care Home Residents
Care home residents have high rates of hospital admission. The UK National Early Warning Score (NEWS2) standardizes the secondary care response to acute illness. However, the ability of NEWS2 to predict adverse health outcomes specifically for care home residents is unknown. This study explored the relatio...
Caring for the Ages
April 2, 2019
National Healthcare Decisions Day Promotes Year-Round Conversations
JAMDA
August 13, 2022
National Monitoring of Medication-Related Quality of Care in Residential Aged Care: Is Australia Making Progress?
Caring for the Ages
October 31, 2023
National POLST Collaborative Evolves
Policy Snapshot
January 12, 2024
National Stakeholder Call with the CMS Administrator
Please join Centers for Medicare & Medicaid Services (CMS) Administrator Chiquita Brooks-LaSure and her leadership team, who will highlight CMS’ key 2023 accomplishments and look ahead to how CMS’ 2024 priorities will advance the CMS Strategic Plan.
JAMDA
February 29, 2024
National Trends in Antidepressant Use in Australian Residential Aged Care Facilities (2006–2019)
Antipsychotics have been the focus of reforms for improving the appropriateness of psychotropic medicine use in residential aged care facilities (RACFs). Comprehensive evaluation of antidepressant use in RACFs is required to inform policy and practice initiatives targeting psychotropic medicines. This stud...
JAMDA
March 24, 2016